novo nordisk weight loss - Search News

News

Novo Nordisk ousts CEO

The New York Times · 1d

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Associated Press News on MSN · 1d

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Reuters on MSN · 1d

Novo Nordisk ousts CEO after falling behind in weight loss market

Pedersen and Stine Jacobsen COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

1don MSN

Novo Nordisk announces CEO transition as share price slips

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

1d

Why Novo Nordisk Stock Just Slipped

Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.

1d

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results